drugset / Trial / NCT00235521

Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery

NCT00235521

Completed 15 enrolled Heidelberg University
RandomizedParallel-groupOpen-labelTreatment

Summary

Inhaled nitrous oxide (iNO) will be compared to aerosolized iloprost (ILO) in pediatric patients after cardiac surgery with pulmonary hypertension. The hypothesis is that iloprost is more effective in preventing pulmonary hypertensive crises.

Timeline

Start
2005-05
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Iloprost Other / unclassified 0.5 ug/kg Inhaled